mGlu2 and mGlu3 Negative Allosteric Modulators Divergently Enhance Thalamocortical Transmission and Exert Rapid Antidepressant-like Effects
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Summary Non-selective antagonists of metabotropic glutamate receptor subtypes 2 (mGlu2) and 3 (mGlu3) exert rapid antidepressant-like effects by enhancing prefrontal cortex (PFC) glutamate transmission, however the receptor subtype contributions and underlying mechanisms remain unclear. Here, we leveraged newly developed negative allosteric modulators (NAMs), transgenic mice, and viral-assisted optogenetics to test the hypothesis that selective inhibition of mGlu2 or mGlu3 potentiates PFC excitatory transmission and confers antidepressant efficacy in preclinical models. We found that systemic treatment with an mGlu2 or mGlu3 NAM rapidly activated biophysically unique PFC pyramidal cell ensembles. Mechanistic studies revealed that mGlu2 and mGlu3 NAMs enhance thalamocortical transmission and inhibit long-term depression by mechanistically distinct presynaptic and postsynaptic actions. Consistent with these actions, systemic treatment with either NAM decreased passive coping and reversed anhedonia in two independent chronic stress models, suggesting that both mGlu2 and mGlu3 NAMs induce antidepressant-like effects through related but divergent mechanisms of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Duman, R. S., Aghajanian, G. K., Sanacora, G., & Krystal, J. H. (2016) · Nature Medicine · doi:10.1038/nm.4050 · Cited by 1,750
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Zanos, P., Moaddel, R., Morris, P. J., Riggs, L. M., Highland, J. N., Georgiou, P., Pereira, E. F. R., Albuquerque, E. X., Thomas, C. J., Zarate, C. A., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015198 · Cited by 1,260
Mechanisms of ketamine action as an antidepressant
Zanos, P., & Gould, T. D. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.255 · Cited by 1,127
Siegle, G. J., Thompson, W., Carter, C. S., Steinhauer, S. R., & Thase, M. E. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.048 · Cited by 857
Hasler, G., van der Veen, J. W., Tumonis, T., Meyers, N., Shen, J., & Drevets, W. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.2.193 · Cited by 846
Decreased expression of synapse-related genes and loss of synapses in major depressive disorder
Kang, H. J., Voleti, B., Hajszan, T., Rajkowska, G., Stockmeier, C. A., Licznerski, P., Lepack, A., Majik, M. S., Jeong, L. S., Banasr, M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2886 · Cited by 808
Stress weakens prefrontal networks: molecular insults to higher cognition
Arnsten, A. F. T. (2015) · Nature Neuroscience · doi:10.1038/nn.4087 · Cited by 752
Gaynes, B. N., Warden, D., Trivedi, M. H., Wisniewski, S. R., Fava, M., & Rush, A. J. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.11.1439 · Cited by 661
Wellman, C. L. (2001) · Journal of Neurobiology · doi:10.1002/neu.1079 · Cited by 594
Targeting cells with single vectors using multiple-feature Boolean logic
Fenno, L. E., Mattis, J., Ramakrishnan, C., Hyun, M., Lee, S. Y., He, M., Tucciarone, J., Selimbeyoglu, A., Berndt, A., Grosenick, L., et al. (2014) · Nature Methods · doi:10.1038/nmeth.2996 · Cited by 557
Research works printed but not linked: 52
- Anastasiades, 2018, Cell-type specificity of callosally evoked excitation and feedforward inhibition in the prefrontal cortex, Cell Rep., 22, 679, 10.1016/j.celrep.2017.12.073 · DOI · Paper page
- Anastasiades, 2019, Cell-type-specific D1 dopamine receptor modulation of projection neurons and interneurons in the prefrontal cortex, Cereb. Cortex, 29, 3224, 10.1093/cercor/bhy299 · DOI · Paper page
- Barth, 2004, Alteration of neuronal firing properties after in vivo experience in a FosGFP transgenic mouse, J. Neurosci., 24, 6466, 10.1523/JNEUROSCI.4737-03.2004 · DOI · Paper page
- Bocchio, 2019, Group II metabotropic glutamate receptors mediate presynaptic inhibition of excitatory transmission in pyramidal neurons of the human cerebral cortex, Front. Cell. Neurosci., 12, 508, 10.3389/fncel.2018.00508 · DOI
- Bollinger, 2017, Design and synthesis of mGlu2 NAMs with improved potency and CNS penetration based on a truncated picolinamide core, ACS Med. Chem. Lett., 8, 919, 10.1021/acsmedchemlett.7b00279 · doi:10.1021/acsmedchemlett.7b00279
- Caetano, 2006, Smaller cingulate volumes in unipolar depressed patients, Biol. Psychiatry, 59, 702, 10.1016/j.biopsych.2005.10.011 · DOI
- Chaki, 2017, mGlu2/3 receptor antagonists as novel antidepressants, Trends Pharmacol. Sci., 38, 569, 10.1016/j.tips.2017.03.008 · DOI · Paper page
- Collins, 2018, Reciprocal circuits linking the prefrontal cortex with dorsal and ventral thalamic nuclei, Neuron, 98, 366, 10.1016/j.neuron.2018.03.024 · DOI · Paper page
- Cryan, 2005, The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice, Neurosci. Biobehav. Rev., 29, 571, 10.1016/j.neubiorev.2005.03.009 · DOI · Paper page
- Di Menna, 2018, Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system, Neuropharmacology, 128, 301, 10.1016/j.neuropharm.2017.10.026 · DOI
- Dong, 2017, Rapid and sustained antidepressant action of the mGlu2/3 receptor antagonist MGS0039 in the social defeat stress model: comparison with ketamine, Int. J. Neuropsychopharmacol., 20, 228
- Engers, 2015, Discovery of a selective and CNS penetrant negative allosteric modulator of metabotropic glutamate receptor subtype 3 with antidepressant and anxiolytic activity in rodents, J. Med. Chem., 58, 7485, 10.1021/acs.jmedchem.5b01005 · DOI
- Engers, 2017, Design and synthesis of N-aryl phenoxyethoxy pyridinones as highly selective and CNS penetrant mGlu3 NAMs, ACS Med. Chem. Lett., 8, 925, 10.1021/acsmedchemlett.7b00249 · DOI
- Fujioka, 2014, Comprehensive behavioral study of mGluR3 knockout mice: implication in schizophrenia related endophenotypes, Mol. Brain, 7, 31, 10.1186/1756-6606-7-31 · DOI
- Gourley, 2009, Recapitulation and reversal of a persistent depression-like syndrome in rodents, Curr. Protoc. Neurosci. Chapter 9, 10.1002/0471142301.ns0932s49 · DOI · Paper page
- Gourley, 2008, Acute hippocampal brain-derived neurotrophic factor restores motivational and forced swim performance after corticosterone, Biol. Psychiatry, 64, 884, 10.1016/j.biopsych.2008.06.016 · DOI · Paper page
- Harris, 2018, Dorsal BNST α2A-adrenergic receptors produce HCN-dependent excitatory actions that initiate anxiogenic behaviors, J. Neurosci., 38, 8922, 10.1523/JNEUROSCI.0963-18.2018 · DOI
- Hetzenauer, 2008, Individual contribution of metabotropic glutamate receptor (mGlu) 2 and 3 to c-Fos expression pattern evoked by mGlu2/3 antagonism, Psychopharmacology (Berl.), 201, 1, 10.1007/s00213-008-1236-2 · DOI
- Highland, 2019, Group II metabotropic glutamate receptor blockade promotes stress resilience in mice, Neuropsychopharmacology, 44, 1788, 10.1038/s41386-019-0380-1 · DOI
- Jin, 2018, mGluR2 versus mGluR3 metabotropic glutamate receptors in primate dorsolateral prefrontal cortex: postsynaptic mGluR3 strengthen working memory networks, Cereb. Cortex, 28, 974, 10.1093/cercor/bhx005 · DOI · Paper page
- Joffe, 2019, Antidepressant potential of metabotropic glutamate receptor mGlu2 and mGlu3 negative allosteric modulators, Neuropsychopharmacology, 44, 214, 10.1038/s41386-018-0192-8 · DOI
- Joffe, 2016, Cocaine experience enhances thalamo-accumbens N-methyl-D-aspartate receptor function, Biol. Psychiatry, 80, 671, 10.1016/j.biopsych.2016.04.002 · DOI
- Joffe, 2017, GluN1 deletions in D1- and A2A-expressing cell types reveal distinct modes of behavioral regulation, Neuropharmacology, 112, 172, 10.1016/j.neuropharm.2016.03.026 · DOI
- Joffe, 2018, Metabotropic glutamate receptors in alcohol use disorder: physiology, plasticity, and promising pharmacotherapies, ACS Chem. Neurosci., 9, 2188, 10.1021/acschemneuro.8b00200 · DOI
- Joffe, 2019, Metabotropic glutamate receptor subtype 3 gates acute stress-induced dysregulation of amygdalo-cortical function, Mol. Psychiatry, 24, 916, 10.1038/s41380-017-0015-z · DOI
- Joffe, 2019, Mechanisms underlying prelimbic prefrontal cortex mGlu3/mGlu5-dependent plasticity and reversal learning deficits following acute stress, Neuropharmacology, 144, 19, 10.1016/j.neuropharm.2018.10.013 · DOI
- Johnson, 2017, Metabotropic glutamate receptor 2 inhibits thalamically-driven glutamate and dopamine release in the dorsal striatum, Neuropharmacology, 117, 114, 10.1016/j.neuropharm.2017.01.038 · DOI
- Kiritoshi, 2015, Group II mGluRs modulate baseline and arthritis pain-related synaptic transmission in the rat medial prefrontal cortex, Neuropharmacology, 95, 388, 10.1016/j.neuropharm.2015.04.003 · DOI
- Koike, 2013, Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression, Behav. Brain Res., 238, 48, 10.1016/j.bbr.2012.10.023 · DOI
- Krystal, 2013, Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond, Biol. Psychiatry, 73, 1133, 10.1016/j.biopsych.2013.03.026 · DOI · Paper page
- Kupferschmidt, 2015, Brain BLAQ: Post-hoc thick-section histochemistry for localizing optogenetic constructs in neurons and their distal terminals, Front. Neuroanat., 9, 6, 10.3389/fnana.2015.00006 · DOI
- Lahti, 2001, Effects of ketamine in normal and schizophrenic volunteers, Neuropsychopharmacology, 25, 455, 10.1016/S0893-133X(01)00243-3 · DOI · Paper page
- Linden, 2005, Comparison of c-Fos induction in the brain by the mGlu2/3 receptor antagonist LY341495 and agonist LY354740: evidence for widespread endogenous tone at brain mGlu2/3 receptors in vivo, Neuropharmacology, 49, 120, 10.1016/j.neuropharm.2005.05.006 · DOI
- Linden, 2009, Use of MGLUR2 and MGLUR3 knockout mice to explore in vivo receptor specificity of the MGLUR2/3 selective antagonist LY341495, Neuropharmacology, 57, 172, 10.1016/j.neuropharm.2009.05.002 · DOI
- Lipowski, 1987, Delirium (acute confusional states), JAMA, 258, 1789, 10.1001/jama.1987.03400130103041 · DOI · Paper page
- Lourenço Neto, 2000, Differential distribution of metabotropic glutamate receptor subtype mRNAs in the thalamus of the rat, Brain Res., 854, 93, 10.1016/S0006-8993(99)02326-4 · DOI
- Marek, 2000, Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex, J. Pharmacol. Exp. Ther., 292, 76, 10.1016/S0022-3565(24)35262-0 · DOI · Paper page
- Marek, 2001, A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex, Neuroscience, 105, 379, 10.1016/S0306-4522(01)00199-3 · DOI · Paper page
- Miller, 2017, Synaptic regulation of a thalamocortical circuit controls depression-related behavior, Cell Rep., 20, 1867, 10.1016/j.celrep.2017.08.002 · DOI · Paper page
- Moghaddam, 1998, Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats, Science, 281, 1349, 10.1126/science.281.5381.1349 · DOI · Paper page
- Nicoletti, 2019, Targeting mGlu receptors for optimization of antipsychotic activity and disease-modifying effect in schizophrenia, Front. Psychiatry, 10, 49, 10.3389/fpsyt.2019.00049 · DOI
- Ohishi, 1993, Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat, Neuroscience, 53, 1009, 10.1016/0306-4522(93)90485-X · DOI · Paper page
- Ohishi, 1993, Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study, J. Comp. Neurol., 335, 252, 10.1002/cne.903350209 · DOI · Paper page
- Rajkowska, 2000, Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells, Biol. Psychiatry, 48, 766, 10.1016/S0006-3223(00)00950-1 · DOI · Paper page
- Solich, 2008, Effect of two behavioral tests on corticosterone level in plasma of mice lacking the noradrenaline transporter, Pharmacol. Rep., 60, 1008
- Sturm, 2015, Effect of chronic corticosterone application on depression-like behavior in C57BL/6N and C57BL/6J mice, Genes Brain Behav., 14, 292, 10.1111/gbb.12208 · DOI · Paper page
- Thuault, 2013, Prefrontal cortex HCN1 channels enable intrinsic persistent neural firing and executive memory function, J. Neurosci., 33, 13583, 10.1523/JNEUROSCI.2427-12.2013 · DOI · Paper page
- Vardy, 2015, A new DREADD facilitates the multiplexed chemogenetic interrogation of behavior, Neuron, 86, 936, 10.1016/j.neuron.2015.03.065 · DOI · Paper page
- Walker, 2015, Metabotropic glutamate receptor 3 activation is required for long-term depression in medial prefrontal cortex and fear extinction, Proc. Natl. Acad. Sci. USA, 112, 1196, 10.1073/pnas.1416196112 · DOI · Paper page
- Witkin, 2017, Preclinical predictors that the orthosteric mGlu2/3 receptor antagonist LY3020371 will not engender ketamine-associated neurotoxic, motor, cognitive, subjective, or abuse-liability-related effects, Pharmacol. Biochem. Behav., 155, 43, 10.1016/j.pbb.2017.03.001 · DOI
- Woolley, 2008, The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity, Psychopharmacology (Berl.), 196, 431, 10.1007/s00213-007-0974-x · DOI · Paper page
- Yuen, 2012, Repeated stress causes cognitive impairment by suppressing glutamate receptor expression and function in prefrontal cortex, Neuron, 73, 962, 10.1016/j.neuron.2011.12.033 · DOI · Paper page
Cited by
The stressed synapse 2.0: pathophysiological mechanisms in stress-related neuropsychiatric disorders
Sanacora, G., Yan, Z., & Popoli, M. (2022) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00540-x · Cited by 197
Dogra, S., & Conn, P. J. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108687 · Cited by 71
Self-citationNeurobiology of the rapid-acting antidepressant effects of ketamine: impact and opportunities
Shinohara, R., Aghajanian, G. K., & Abdallah, C. G. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.12.006 · Cited by 54
Mou, R., Ma, J., Ju, X., Wu, Y., Chen, Q., Li, J., Shang, T., Chen, S., Yang, Y., Li, Y., et al. (2024) · Cell Stem Cell · doi:10.1016/j.stem.2024.09.018 · Cited by 20
Wegman-Points, L., Pope, B., Zobel-Mask, A., Winter, L., Wauson, E., Duric, V., & Yuan, L.-L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.590221 · Cited by 12
Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery
Tanaka, M. (2026) · Biomedicines · doi:10.3390/biomedicines14061265
Metadata
- Authors
- Joffe, M. E., Santiago, C. I., Oliver, K. H., Maksymetz, J., Harris, N. A., Engers, J. L., Lindsley, C. W., Winder, D. G., & Conn, P. J.
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2020-01
- Volume
- 105
- Issue
- 1
- Pages
- 46-59.e3
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W2946585706
- Cited by
- 76
- References
- 25
- FWCI
- 6.40
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 373 d)
- Funders
- National Institutes of Health
- Pharmaceutical Research and Manufacturers of America Foundation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.